Deutsche Bank Ag\ Cure Vac N.V. Transaction History

Deutsche Bank Ag\

$248 Billion
Q4 2024

A detailed history of Deutsche Bank Ag\ transactions in Cure Vac N.V. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 169,872 shares of CVAC stock, worth $526,603. This represents 0.0% of its overall portfolio holdings.

Number of Shares

169,872

Previous 169,872 -0.0%

Holding current value

$526,603

Previous $499,000 16.03%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$2.74 - $3.79 $51,591 - $71,361	18,829 Added 12.47%	169,872 $499,000
Q2 2024 Aug 14, 2024	BUY	$2.31 - $4.99 $127,165 - $274,699	55,050 Added 57.35%	151,043 $513,000
Q1 2024 May 15, 2024	BUY	$2.94 - $4.34 $74,593 - $110,114	25,372 Added 35.93%	95,993 $290,000
Q4 2023 Feb 14, 2024	SELL	$3.96 - $6.41 $7,480 - $12,108	-1,889 Reduced 2.61%	70,621 $297,000
Q3 2023 Nov 09, 2023	BUY	$6.5 - $10.77 $22,691 - $37,598	3,491 Added 5.06%	72,510 $495,000
Q2 2023 Aug 14, 2023	BUY	$6.69 - $12.25 $104,798 - $191,896	15,665 Added 29.36%	69,019 $719,000
Q1 2023 May 15, 2023	BUY	$6.38 - $12.5 $20,837 - $40,825	3,266 Added 6.52%	53,354 $371,000
Q4 2022 Feb 13, 2023	BUY	$5.75 - $8.5 $46,563 - $68,833	8,098 Added 19.29%	50,088 $302,000
Q3 2022 Nov 14, 2022	SELL	$7.48 - $15.24 $411,392 - $838,184	-54,999 Reduced 56.71%	41,990 $331,000
Q2 2022 Aug 11, 2022	BUY	$13.18 - $19.41 $226,801 - $334,007	17,208 Added 21.57%	96,989 $1.32 Million
Q1 2022 May 13, 2022	BUY	$14.73 - $35.25 $146,268 - $350,032	9,930 Added 14.22%	79,781 $1.57 Million
Q4 2021 Feb 11, 2022	SELL	$33.72 - $48.22 $169,072 - $241,775	-5,014 Reduced 6.7%	69,851 $2.4 Million
Q3 2021 Nov 04, 2021	SELL	$49.26 - $74.5 $436,640 - $660,368	-8,864 Reduced 10.59%	74,865 $4.09 Million
Q2 2021 Aug 11, 2021	SELL	$56.91 - $127.53 $22.5 Million - $50.3 Million	-394,613 Reduced 82.5%	83,729 $6.15 Million
Q1 2021 May 13, 2021	BUY	$79.79 - $126.29 $27.9 Million - $44.2 Million	349,603 Added 271.56%	478,342 $43.7 Million
Q4 2020 Feb 16, 2021	BUY	$46.76 - $136.27 $1.56 Million - $4.55 Million	33,409 Added 35.05%	128,739 $10.4 Million
Q3 2020 Nov 12, 2020	BUY	$43.8 - $77.2 $4.18 Million - $7.36 Million	95,330 New	95,330 $4.44 Million

Others Institutions Holding CVAC

# of Institutions

Shares Held

10.5M

Call Options Held

75.5K

Put Options Held

33.5K

View Full List

About CureVac N.V.

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $581M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

More about CVAC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account